18 Nov 2026, 08:45
Meetings & Governance—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 18 Nov 2026, 08:45 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 17 Nov 2026, 11:37 | AGM Managing Director's Presentation | Presentations | — | 03026, 15002 | |
| 17 Nov 2026, 11:35 | Chair's Address to Shareholders | Letters & Addresses | — | 15002 | |
| 10 Nov 2026, 10:30 | Notification regarding unquoted securities - CC5 | Securities Administration | — | 06021 | |
| 10 Nov 2026, 10:20 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 | |
| 3 Nov 2026, 10:20 | Proposed issue of securities - CC5 | Securities Administration | — | 06013 | |
| 3 Nov 2026, 10:20 | Funding Raised for Development of a New Benchtop Instrument | Capital Raising | MS | 03022, 06003, 09014, 11001 | |
| 30 Oct 2026, 09:08 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 30 Oct 2026, 08:30 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 29 Oct 2026, 15:29 | Change of Registry Address Notification | Securities Administration | — | 12004 | |
| 28 Oct 2026, 08:21 | Advancing Sales Pipeline Underpins Growth Momentum | Company Update | MS | 11001 | |
| 14 Oct 2026, 08:23 | PSC Biotech Partnership Expands US Pharma Sales Reach | Company Update | MS | 11001, 12008 | |
| 13 Oct 2026, 17:27 | Proposed issue of securities - CC5 | Securities Administration | — | 06013 | |
| 13 Oct 2026, 17:12 | Proposed issue of securities - CC5 | Securities Administration | — | 06013 | |
| 13 Oct 2026, 16:54 | Notice of Annual General Meeting/Proxy Form | Presentations | — | 08001, 08004, 14014 | |
| 7 Sept 2026, 09:56 | Novo Nordisk Expand Use of APAS Independence | Company Update | MS | 11001 | |
| 31 Aug 2026, 10:26 | Appendix 4G | Company Administration | — | 03025 | |
| 31 Aug 2026, 10:25 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 31 Aug 2026, 10:25 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 31 Aug 2026, 09:44 | Appendix 4E | Financial Results | MS | 03003 | |
| 14 Aug 2026, 09:37 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 | |
| 13 Aug 2026, 10:01 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 10 Aug 2026, 10:02 | Notification of cessation of securities - CC5 | Securities Administration | — | 06027 | |
| 6 Aug 2026, 10:03 | Proposed issue of securities - CC5 | Securities Administration | — | 06013 | |
| 6 Aug 2026, 09:38 | Proposed issue of securities - CC5 | Securities Administration | — | 06013 | |
| 30 July 2026, 09:39 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 1 July 2026, 16:42 | Notification regarding unquoted securities - CC5 | Securities Administration | — | 06021 | |
| 29 June 2026, 13:03 | Proposed issue of securities - CC5 | Securities Administration | — | 06013 | |
| 23 June 2026, 08:52 | Notification regarding unquoted securities - CC5 | Securities Administration | — | 06021 | |
| 23 June 2026, 08:30 | Updated Company Presentation | Presentations | — | 03026 | |
| 22 June 2026, 10:54 | Proposed issue of securities - CC5 | Securities Administration | — | 06013 | |
| 9 June 2026, 09:41 | CSL Orders APAS Independence for Global QC Operations | Company Update | — | 11001 | |
| 28 May 2026, 08:50 | Sales and Commercial Update | Company Update | — | 11001 | |
| 13 May 2026, 15:49 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 | |
| 30 Apr 2026, 09:46 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19003, 19008 | |
| 29 Apr 2026, 10:01 | Investor Conference Call Notification | Presentations | — | 03027, 14014 | |
| 20 Apr 2026, 08:42 | Notification of cessation of securities - CC5 | Securities Administration | — | 06027 | |
| 17 Feb 2026, 09:51 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 12 Feb 2026, 08:15 | Notice Under Section 708A - Cleansing Notice | Securities Administration | — | 06018 | |
| 12 Feb 2026, 08:15 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 | |
| 11 Feb 2026, 09:57 | Company Presentation | Presentations | — | 03026 | |
| 28 Jan 2026, 08:19 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19002, 19007 | |
| 21 Jan 2026, 09:16 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 24 Dec 2025, 11:34 | Notice Under Section 708A - Cleansing Notice | Securities Administration | — | 06018 | |
| 24 Dec 2025, 11:32 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 | |
| 3 Dec 2025, 15:56 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 3 Dec 2025, 15:54 | Notice Under Section 708A - Cleansing Notice | Securities Administration | — | 06018 | |
| 3 Dec 2025, 15:48 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 | |
| 20 Nov 2025, 08:23 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 | |
| 20 Nov 2025, 08:23 | Application for quotation of securities - CC5 | Securities Administration | — | 06020 |